Jos Van Houdt

936 total citations
15 papers, 515 citations indexed

About

Jos Van Houdt is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Jos Van Houdt has authored 15 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Jos Van Houdt's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Analytical Chemistry and Chromatography (2 papers). Jos Van Houdt is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Analytical Chemistry and Chromatography (2 papers). Jos Van Houdt collaborates with scholars based in Belgium, United Kingdom and Spain. Jos Van Houdt's co-authors include W. Meuldermans, Jan Hendrickx, J. Heykants, Karel Lavrijsen, Geert Mannens, Hilde Bohets, Martin Armstrong, Stuart Dunn, Charles L. Crespi and Ann K. Daly and has published in prestigious journals such as Journal of Hepatology, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Jos Van Houdt

15 papers receiving 490 citations

Peers

Countries citing papers authored by Jos Van Houdt

Since Specialization

Citations

This map shows the geographic impact of Jos Van Houdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Van Houdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Van Houdt more than expected).

Fields of papers citing papers by Jos Van Houdt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Van Houdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Van Houdt. The network helps show where Jos Van Houdt may publish in the future.

Co-authorship network of co-authors of Jos Van Houdt

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Van Houdt. A scholar is included among the top collaborators of Jos Van Houdt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Van Houdt. Jos Van Houdt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Göttingen Minipigs 2017 ·Pharmaceutical Research ·(unknown), Frank Jacobs, Jan Snoeys, Jos Van Houdt, (unknown), Christophe Casteleyn, Chris Van Ginneken, Steven Van Cruchten	11
2	In vitro studies on the metabolism of trabectedin (YONDELIS®) in monkey and man, including human CYP reaction phenotyping 2009 ·Biochemical Pharmacology ·Marc Vermeir, Alex Hemeryck, Filip Cuyckens, Andrés Francesch, (unknown), Jos Van Houdt, (unknown), Geert Mannens, Pablo Avilés, R. De Coster	18
3	855 ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER 2008 ·Journal of Hepatology ·(unknown), (unknown), (unknown), (unknown), Marieke Voets, Jos Van Houdt, René Verloes, (unknown), (unknown), P. Van Remoortere, F. Broeckaert, Herman de Kock, Kenneth Simmen	3
4	EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES 2005 ·Drug Metabolism and Disposition ·Dirk Roymans, Pieter Annaert, Jos Van Houdt, (unknown), (unknown), Carlo Sensenhauser, José Silva, (unknown), Jan Hendrickx, Geert Mannens, W. Meuldermans	56
5	CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes 2002 ·Biochemical Pharmacology ·(unknown), Julian Leathart, Elaine Mutch, (unknown), Stuart Dunn, Ron Gilissen, Jos Van Houdt, Jan Hendrickx, Geert Mannens, Hilde Bohets, Faith M. Williams, Martin Armstrong, Charles L. Crespi, Ann K. Daly	197
6	Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co‐medication interactions 2000 ·British Journal of Pharmacology ·Hilde Bohets, Karel Lavrijsen, Jan Hendrickx, Jos Van Houdt, (unknown), Pieter Verboven, W. Meuldermans, J. Heykants	45
7	Reduction of the prodrug loperamide oxide to its active drug loperamide in the gut of rats, dogs, and humans. 1995 ·Drug Metabolism and Disposition ·Karel Lavrijsen, D. Van Dyck, Jos Van Houdt, Jan Hendrickx, Johan Monbaliu, Robert Woestenborghs, W. Meuldermans, J Heykants	46
8	Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes 1992 ·Xenobiotica ·Karel Lavrijsen, Jos Van Houdt, D. Van Dyck, Jan Hendrickx, (unknown), R Hurkmans, W. Meuldermans, L. Le Jeune, W. Lauwers, J. Heykants	28
9	Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans. 1990 ·Drug Metabolism and Disposition ·Karel Lavrijsen, Jos Van Houdt, D. Van Dyck, Jan Hendrickx, W. Lauwers, R Hurkmans, (unknown), C. Janssen, W. Meuldermans, J. Heykants	11
10	Effect of the fungicide imazalil on hepatic microsomal cytochrome P‐450 and cytochrome P‐450 dependent activities in the Bobwhite quail (Colinus virginianus) 1990 ·Pesticide Science ·Karel Lavrijsen, Jos Van Houdt, D. Van Dyck, W. Meuldermans, J. Heykants	4
11	Metabolism of alfentanil by isolated hepatocytes of rat and dog 1988 ·Xenobiotica ·Karel Lavrijsen, Jos Van Houdt, W. Meuldermans, (unknown), Jan Hendrickx, W. Lauwers, R Hurkmans, J. Heykants	3
12	In Vitro Screening for Hepatotoxicity of Xenobiotics using Isolated Hepatocytes 1988 ·Alternatives to Laboratory Animals ·Karel Lavrijsen, (unknown), Jos Van Houdt, (unknown), W. Meuldermans, J. Heykants	2
13	Plasma protein binding of ketanserin and its distribution in blood. 1988 ·PubMed ·W. Meuldermans, Jos Van Houdt, (unknown), (unknown), (unknown), J. Heykants	8
14	Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsornes 1987 ·Xenobiotica ·Karel Lavrijsen, Jos Van Houdt, (unknown), W. Meuldermans, J. Heykants	37
15	Induction potential of antifungals containing an imidazole or triazole moiety 1986 ·Biochemical Pharmacology ·(unknown), Jos Van Houdt, (unknown), W. Meuldermans, J. Heykants	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact